Tuesday, June 15, 2010


During this clinic appointment, I was very excited about being in a Phase 2 PV study for an Interferon 2 Alpha (IF2A) study that had shown great promise. I had studied all of the preceding publications with the IF2A and had convinced myself that this was the "promised land" and that I finally had the hope of being cured from PV.

During the appointment, Dr. Prchal told me that because of my other genetic issues, I would not be accepted as a candidate for this study. I was devastated! However, Dr. Prchal told me about a Phase 1 study (first human consumption) with Eli Lily. The drug has shown promise with mice and dogs - and now needs human rats (or guinea pigs). I will go through the screening in late June and start the study in July.